G1 THERAPEUTICS INC (GTHX)

US3621LQ1099 - Common Stock

4.32  -0.15 (-3.36%)

After market: 4.32 0 (0%)

Buy % Consensus

80

ChartMill assigns a Buy % Consensus number of 80% to GTHX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 8.67. This target is 100.69% above the current price.
GTHX was analyzed by 12 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about GTHX.
In the previous month the buy percentage consensus was at a similar level.
GTHX was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 4.325.058.678.6712.60 - 16.90% 100.69% 100.69% 191.67%
Up and Down Grades
Date Firm Action Rating
2024-02-28 Needham Reiterate Buy -> Buy
2024-02-13 Needham Maintains Buy -> Buy
2024-02-13 Wedbush Maintains Outperform -> Outperform
2024-01-24 Needham Reiterate Buy -> Buy
2023-12-06 Needham Reiterate Buy -> Buy
2023-10-30 Wedbush Reiterate Outperform -> Outperform
2023-10-06 JP Morgan Downgrade Neutral -> Underweight
2023-08-03 Wedbush Reiterate Outperform -> Outperform
2023-08-03 HC Wainwright & Co. Reiterate Buy -> Buy
2023-08-02 EF Hutton Reiterate Buy
2023-08-02 Needham Maintains Buy -> Buy
2023-06-26 HC Wainwright & Co. Reiterate Buy -> Buy
2023-06-05 Needham Reiterate Buy -> Buy
2023-06-05 HC Wainwright & Co. Reiterate Buy -> Buy
2023-05-04 Raymond James Maintains Outperform
2023-05-04 HC Wainwright & Co. Reiterate Buy
2023-04-19 Needham Reiterate Buy
2023-03-02 HC Wainwright & Co. Reiterate Buy
2023-02-14 Needham Maintains Buy
2023-02-14 HC Wainwright & Co. Maintains Buy
2023-02-13 EF Hutton Maintains Buy
2023-01-30 JP Morgan Upgrade Underweight -> Neutral
2023-01-05 EF Hutton Initiate Buy
2023-01-03 Needham Maintains Buy
2022-11-02 HC Wainwright & Co. Maintains Buy
2022-09-16 Wedbush Maintains Outperform
2022-08-04 Needham Maintains Buy
2022-05-05 Needham Maintains Buy
2021-11-04 Raymond James Maintains Outperform
2021-11-04 JP Morgan Downgrade Neutral -> Underweight